Adma Biologics, Inc.
Current role
ADMA
Young T. Kwon, PhD
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Young T. Kwon, PhD
Adma Biologics, Inc. reported in an 8-K filed November 21, 2024 that Young T. Kwon, PhD was appointed Chairman of the Company's Audit Committee, effective November 19, 2024.
“On November 19, 2024, Young T. Kwon, PhD was appointed as Chairman of the Company's Audit Committee and designated as an "audit committee financial expert", as such term is defined in Securities and Exchange Commission rules, Steven A. Elms was added as a member of the Company's Audit Committee, and Alison C. Finger was added as a member of the Company's Governance and Nominations Committee and Compensation Committee.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Adma Biologics, Inc. (ADMA)
SEC 8-K
Current2024-11-19–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Adma Biologics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jerrold B CEO, Board Member
- Steven A. Elms Chairman
- Adam Grossman CFO
- Brad L. Tade CFO
- Brad Tade CFO
- Eduardo Rene Salas CFO, Board Member
- Paul Terence Kohler CFO
- Alison C. Finger COO, Board Member
- Kaitlin Kestenberg COO
- Young T. Kwon, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.